Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESKISE trial of esketamine versus racemic ketamine for emergency procedural sedation
2026-527265-30-00Phase 4Withdrawn
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarticular injury comparing Esketamine arm with Ketamine arm (2 arms). Primary endpoint: Poor-quality awakening. Planned start Oct 2026; status: withdrawn.
02
Drugs
esketamineketamine
03
Conditions
osteoarticular injury
Beyond the preview
Go deeper on 2026-527265-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-527265-30-00.